IceCure Medical (ICCM) Shares Outstanding (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Shares Outstanding data on file, last reported at $73.1 million in Q4 2025.

• Quarterly Shares Outstanding rose 29.26% year-over-year to $73.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73.1 million (up 29.26% YoY) and the FY2025 annual result came in at $73.1 million, up 29.26% from the prior year.
• Shares Outstanding advanced to $73.1 million in Q4 2025 per ICCM's latest filing, from $56.6 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $73.1 million in Q4 2025 and bottomed at $1.0 million in Q4 2021.
• The 5-year median for Shares Outstanding is $45.7 million (2023), against an average of $44.4 million.
• The widest annual swing landed in 2021, when Shares Outstanding surged 19128.34%; it then climbed 0.23% in 2023.
• Tracing ICCM's Shares Outstanding over 5 years: stood at $1.0 million in 2021, then soared by 4312.32% to $45.6 million in 2022, then climbed by 0.23% to $45.7 million in 2023, then grew by 23.7% to $56.6 million in 2024, then grew by 29.26% to $73.1 million in 2025.
• Per Business Quant, the three latest ICCM Shares Outstanding figures stand at $73.1 million (Q4 2025), $56.6 million (Q4 2024), and $45.7 million (Q4 2023).

Peer Comparison